Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
2441
-
Total 13F shares, excl. options
-
1.27B
-
Shares change
-
+1.85M
-
Total reported value, excl. options
-
$139B
-
Value change
-
+$205M
-
Put/Call ratio
-
0.91
-
Number of buys
-
997
-
Number of sells
-
-956
-
Price
-
$109.49
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q4 2020
2,579 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q4 2020.
ABBOTT LABORATORIES - COM (ABT) has 2,441 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.27B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (147M shares), BlackRock Inc. (133M shares), Capital Research Global Investors (86.4M shares), STATE STREET CORP (71.3M shares), Capital International Investors (53.6M shares), WELLINGTON MANAGEMENT GROUP LLP (31.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (27.1M shares), MORGAN STANLEY (26.7M shares), NORTHERN TRUST CORP (26.4M shares), and BANK OF AMERICA CORP /DE/ (23.9M shares).
This table shows the top 2441 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.